
TY  - JOUR
TI  - Nutrition Basic Science
JO  - Journal of Gastroenterology and Hepatology
VL  - 27
IS  - s4
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2011.07251_8.x
DO  - doi:10.1111/j.1440-1746.2011.07251_8.x
SP  - 139
EP  - 139
PY  - 2012
ER  - 

TY  - JOUR
TI  - Basic Science Luminal
JO  - Journal of Gastroenterology and Hepatology
VL  - 27
IS  - s4
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2011.07251_2.x
DO  - doi:10.1111/j.1440-1746.2011.07251_2.x
SP  - 17
EP  - 29
PY  - 2012
ER  - 

TY  - JOUR
TI  - Lectures 6 June 2008
JO  - Obesity Reviews
VL  - 9
IS  - s2
SN  - 1467-7881
UR  - https://doi.org/10.1111/j.1467-789X.2008.00486.x
DO  - doi:10.1111/j.1467-789X.2008.00486.x
SP  - 7
EP  - 13
PY  - 2008
ER  - 

TY  - JOUR
TI  - Paediatrics
JO  - Journal of Gastroenterology and Hepatology
VL  - 27
IS  - s4
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2011.07251_11.x
DO  - doi:10.1111/j.1440-1746.2011.07251_11.x
SP  - 158
EP  - 160
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Nephrology
VL  - 14
IS  - s1
SN  - 1320-5358
UR  - https://doi.org/10.1111/j.1440-1797.2009.01176.x
DO  - doi:10.1111/j.1440-1797.2009.01176.x
SP  - A1
EP  - A56
PY  - 2009
ER  - 

TY  - JOUR
C7  - e25187
TI  - HIV Glasgow 2018, 28â€“31 October 2018, Glasgow, UK
JO  - Journal of the International AIDS Society
JA  - J Intern AIDS Soc
VL  - 21
IS  - S8
SN  - 1758-2652
UR  - https://doi.org/10.1002/jia2.25187
DO  - doi:10.1002/jia2.25187
SP  - e25187
PY  - 2018
ER  - 

TY  - JOUR
TI  - Viral Hepatitis
JO  - Journal of Gastroenterology and Hepatology
VL  - 27
IS  - s4
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2011.07251_12.x
DO  - doi:10.1111/j.1440-1746.2011.07251_12.x
SP  - 161
EP  - 182
PY  - 2012
ER  - 

TY  - JOUR
TI  - Oral and Poster Presentations
JO  - Catheterization and Cardiovascular Interventions
JA  - Cathet. Cardiovasc. Intervent.
VL  - 77
IS  - S1
SN  - 1522-1946
UR  - https://doi.org/10.1002/ccd.23089
DO  - doi:10.1002/ccd.23089
SP  - S1
EP  - S156
PY  - 2011
ER  - 

TY  - JOUR
TI  - Poster Session Abstracts
JO  - Pediatric Pulmonology
JA  - Pediatr Pulmonol.
VL  - 49
IS  - S38
SN  - 8755-6863
UR  - https://doi.org/10.1002/ppul.23108
DO  - doi:10.1002/ppul.23108
SP  - S216
EP  - S456
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Session 3 Cell and Molecular Biology
JO  - Obesity
VL  - 17
IS  - S2
SN  - 1930-7381
UR  - https://doi.org/10.1038/oby.2009.286
DO  - doi:10.1038/oby.2009.286
SP  - S243
EP  - S315
PY  - 2009
ER  - 

TY  - JOUR
TI  - IBD Clinical
JO  - Journal of Gastroenterology and Hepatology
VL  - 27
IS  - s4
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2011.07251_6.x
DO  - doi:10.1111/j.1440-1746.2011.07251_6.x
SP  - 96
EP  - 122
PY  - 2012
ER  - 

TY  - JOUR
TI  - Nutrition Clinical
JO  - Journal of Gastroenterology and Hepatology
VL  - 27
IS  - s4
SN  - 0815-9319
UR  - https://doi.org/10.1111/j.1440-1746.2011.07251_9.x
DO  - doi:10.1111/j.1440-1746.2011.07251_9.x
SP  - 140
EP  - 149
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Sleep Research
JA  - J Sleep Res
VL  - 25
IS  - S1
SN  - 0962-1105
UR  - https://doi.org/10.1111/jsr.12446
DO  - doi:10.1111/jsr.12446
SP  - 5
EP  - 377
PY  - 2016
ER  - 

TY  - JOUR
TI  - Clinical care and other categories posters
JO  - Diabetic Medicine
VL  - 28
IS  - s1
SN  - 0742-3071
UR  - https://doi.org/10.1111/j.1464-5491.2011.03233_2.x
DO  - doi:10.1111/j.1464-5491.2011.03233_2.x
SP  - 83
EP  - 203
PY  - 2011
ER  - 

TY  - JOUR
TI  - Abstracts and Index of Authors
JO  - Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy
JA  - Pharmacotherapy
VL  - 33
IS  - 10
SN  - 0277-0008
UR  - https://doi.org/10.1002/phar.1356
DO  - doi:10.1002/phar.1356
SP  - e182
EP  - e332
PY  - 2013
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - American Journal of Transplantation
VL  - 18
IS  - S4
SN  - 1600-6135
UR  - https://doi.org/10.1111/ajt.14918
DO  - doi:10.1111/ajt.14918
SP  - 479
EP  - 991
PY  - 2018
ER  - 

TY  - JOUR
TI  - Brief Orals
JO  - Transplant International
JA  - Transpl Int
VL  - 30
IS  - S2
SN  - 0934-0874
UR  - https://doi.org/10.1111/tri.13050
DO  - doi:10.1111/tri.13050
SP  - 165
EP  - 346
PY  - 2017
ER  - 

TY  - JOUR
TI  - The 2nd Congress of Asian Society for Pediatric Research
JO  - Pediatrics International
VL  - 49
IS  - 5
SN  - 1328-8067
UR  - https://doi.org/10.1111/j.1442-200X.2007.02473.x
DO  - doi:10.1111/j.1442-200X.2007.02473.x
SP  - 691
EP  - 792
PY  - 2007
ER  - 

TY  - JOUR
AU  - Avan, Amir
AU  - Tavakoly Sany, Seyedeh Belin
AU  - Ghayour-Mobarhan, Majid
AU  - Rahimi, Hamid Reza
AU  - Tajfard, Mohammad
AU  - Ferns, Gordon
TI  - Serum C-reactive protein in the prediction of cardiovascular diseases: Overview of the latest clinical studies and public health practice
JO  - Journal of Cellular Physiology
JA  - J Cell Physiol
VL  - 233
IS  - 11
SN  - 0021-9541
UR  - https://doi.org/10.1002/jcp.26791
DO  - doi:10.1002/jcp.26791
SP  - 8508
EP  - 8525
KW  - angiography
KW  - cardiovascular diseases (CVD)
KW  - C-reactive protein (CRP)
KW  - inflammatory biomarkers
PY  - 2018
AB  - Cardiovascular disease is the most common cause of morbidity and mortality globally. Epidemiological studies using high-sensitivity assays for serum C-reactive protein have shown a consistent association between cardiovascular disease risk and serum C-reactive protein concentrations. C-reactive protein is a biomarker for inflammation, and has been established in clinical practice as an independent risk factor for cardiovascular disease events. There is evidence that serum C-reactive protein is an excellent biomarker of cardiovascular disease and is also an independent and strong predictor of adverse cardiovascular events. Further characterization of the impact and influence of lifestyle exposures and genetic variation on the C-reactive protein response to cardiovascular disease events may have implications for the therapeutic approaches to reduce cardiovascular disease events. This review summarizes the studies that have examined the association between serum C-reactive protein and the risk of cardiovascular disease. We also discuss the impact of independent factors and C-reactive protein genetic polymorphisms on baseline plasma C-reactive protein levels.
ER  - 

TY  - JOUR
AU  - Khazim, Khaled
AU  - Azulay, Etti Ester
AU  - Kristal, Batya
AU  - Cohen, Idan
TI  - Interleukin 1 gene polymorphism and susceptibility to disease
JO  - Immunological Reviews
JA  - Immunol Rev
VL  - 281
IS  - 1
SN  - 0105-2896
UR  - https://doi.org/10.1111/imr.12620
DO  - doi:10.1111/imr.12620
SP  - 40
EP  - 56
KW  - cytokines
KW  - inflammation
KW  - interleukin 1
KW  - polymorphism
PY  - 2018
AB  - Summary The Interleukin 1 (IL-1) family plays a central role in the generation and regulation of inflammatory responses, in both innate and adaptive immunity. Although the IL-1 molecules are traditionally considered to be classical proinflammatory cytokines, their functions are not restricted to inflammation, and they have also been shown to play a key role in a wide range of additional physiological and pathological functions, including learning modulation, sleep, pregnancy, depression, appetite, hematopoiesis, metabolism, and many others. Since their effect as cytokines and regulators of inflammation is so pleiotropic, any shift of the biological balance between agonistic and antagonistic signals has the potential to cause disease. Here, we consider the genetic influence of interleukin-1 gene polymorphism in the context of susceptibility to human diseases. We review known single nucleotide polymorphisms (SNP) of IL-1 genes linked to human diseases, and suggest how exploring biological effects of IL-1 gene cluster polymorphism may lead to new directions in understanding and diagnostic of disease and effective treatment.
ER  - 
